NCT Number: NCT00482898
A Study of MK0359 in Patients With Chronic Asthma (0359-013)
A study to test the effect of MK0359 in lessening the symptoms of asthma as compared to placebo.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–45 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- You are between the ages of 18 and 45
- You have had a history for at least a year of COPD symptoms
- Your current asthma treatment is limited to short-acting beta-agonists(such as albuterol)
- You have a history of smoking one pack of cigarettes per day for 7 years
- You will not be away from home for more than 5 days during the study
Exclusion criteria
- You are unwilling to limit your alcohol use to less than 5 drinks per week
- You have been in a research study with an investigational drug or vaccine in the last 4 weeks
- You have donated blood in the last 4 weeks
- You have been hospitalized or had major surgery in the last 4 weeks
- You have been treated in the emergency room within the last 4 weeks or hospitalized within the last 3 months for your asthma
- You have a history of heart problems in the last 6 months
- You have a history of stomach problems
- You are unwilling to avoid grapefruit juice throughout the study
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Official study title
A Multicenter, Randomized, Double-Blind, Crossover Study Comparing the Effect of MK0359 and Placebo in Adult Patients With Chronic Asthma
Important dates
- Study start
- 2002
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- Jun 5, 2007
- Registry last updated
- May 27, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Agricultural Health Study Follow-up
NCT01399411
Asthma, Autoimmune Diseases
Iowa City, Illinois, United States
View Trial DetailsThe COX-2 Gene and the Immune System
NCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial DetailsSample Collections From the Airways of Asthmatic Patients
NCT00001888
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsSU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA
NCT07746570
Asthma, Bronchial Diseases
Erzincan, Merkez, Turkey (Türkiye)
View Trial Details